产品
编 号:F068716
分子式:C27H29N5O
分子量:439.55
产品类型
结构图
CAS No: 1202580-59-3
联系客服
产品详情
生物活性:
GPP78 (CAY10618) is a potent Nampt inhibitor with an IC50 of 3.0 nM for nicotinamide adenine dinucleotide (NAD) depletion. GPP78 is cytotoxic to neuroblastoma cell line SH-SY5Y cells with an IC50 of 3.8 nM by inducing autophagy. GPP78 has anti-cancer and anti-inflammatory effects.
体内研究:
GPP78 (10 mg/kg; intraperitoneal injection; daily; 1 hour or 6 hours after SCI; for 19 days; male adult CD1 mice) treatment reduces the severity of spinal cord trauma in SCI mice.Animal Model:Male adult CD1 mice (25-30 g) with spinal cord injury (SCI)
Dosage:10 mg/kg
Administration:Intraperitoneal injection; daily; 1 hour or 6 hours after SCI; for 19 days
Result:Significantly reduced the demyelination associated with SCI. And significantly ameliorated the functional deficits induced by SCI.
体外研究:
GPP78 (Compound 8; 10 nM; 24-40 hours; SH-SY5Y cells) treatment with cells, punctate staining of LC3-II and the formation of autophagolysosomes are observable. LC3-II is membrane-bound and is present in autophagosomes.GPP78 (Compound 8) inhibits the growth of most cell lines tested, with nanomolar potency (GI50) in cell lines derived from leukemia, lung, CNS, colon, melanoma, ovarian, renal, and prostate cancers. GPP78 appears truly cytotoxic in melanoma cell lines, while in the others it is mainly cytostatic.